PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Wickham Laboratories Holdings Announces Planning Application Approval

Outline planning permission application for expansion of the Hoeford Point site now approved.

Wickham Laboratories Ltd Hoeford Point Site

Wickham Laboratories Holdings, owner of Wickham Laboratories Ltd, today announces approval of its application for planning permission to construct additional buildings on the Hoeford Point site.

These buildings are to be situated adjacent to the current Wickham Laboratories facilities and represent an overall expansion of the group’s business ventures.
This planning application is for 5 separate buildings, constructed over a period of time as yet to be agreed, with an intended use in the area of science and technology.
Wickham Laboratories Holdings is pleased that the application has been approved and planning can now progress for additional facilities to attract further development and jobs to the local area.
Company Overview
As a GMP/GLP compliant laboratory with over 50 years of experience, Wickham Laboratories Ltd is an established name in the fields of pharmaceutical and medical device contract testing, research and consultancy. We conduct business with clients worldwide and the combined expertise of our laboratory technicians and managers enables us to be fully conversant with global regulatory expectations. We are committed to providing a quality testing service, combining high levels of client satisfaction together with the maintenance of appropriate accreditation. This and the continual pursuit of delivering excellence remain central to our business. We are routinely inspected by the MHRA, FDA and Home Office and welcome enquiries from interested parties.
For more information about Wickham Laboratories Limited and our services, please contact us at +44 (0)1329 226600 or mail@wickhamlabs.co.uk. To directly request a company brochure, please visit the Resource Centre section of our company website.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026